Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Alternative chemotherapy combination for cervical cancer investigated
September 15th, 2005
An alternative chemotherapy combination for cervical cancer was recently investigated. Australian investigators stated, "One of the most active chemotherapy combinations in advanced or recurrent cervical cancer is cisplatin-paclitaxel. However, this palliative regimen is associated with significant toxicity." "Carboplatin-paclitaxel is thus an attractive option," wrote A.V. Tinker and colleagues. "Patients with advanced or recurrent carcinoma of the cervix treated with carboplatin-paclitaxel from April 2000 were included in the study. Starting doses of carboplatin-paclitaxel were: AUC 5-6 and 155-175 mg/m2, respectively, repeated every 28...
Source: Women's Health Weekly (2005-09-15)
|
